Skip to main content
. Author manuscript; available in PMC: 2010 May 19.
Published in final edited form as: Eur J Clin Pharmacol. 2009 Nov;65(11):1081–1088. doi: 10.1007/s00228-009-0725-5

Figure 1.

Figure 1

Flow cytometry histograms illustrating 3,3′-diethyloxacarbocyanine iodide [DiOC2(3)] efflux by total CD4+ and CD8+ T cells and near complete inhibition of dye efflux by verapamil (VRP). M1 delineates the cells within the population that are dye efflux negative (bright).